Iqvia Holdings (IQV) Cash & Equivalents (2011 - 2026)
Iqvia Holdings' (IQV) quarterly Cash & Equivalents came in at $1.9 billion in Q2 2026, down 6.38% year-over-year from $2.0 billion in Q2 2025, and down 1.95% quarter-over-quarter from $1.9 billion in Q1 2026.
Analysis
Iqvia Holdings (IQV) Cash & Equivalents (2011 - 2026) Analysis & Trends
Iqvia Holdings has disclosed Cash & Equivalents across 16 years of filings, most recently posting $1.9 billion for Q2 2026.
- In Q2 2026, Cash & Equivalents fell 6.38% year-over-year to $1.9 billion; the TTM figure through Jun 2026 stood at $1.9 billion (down 6.38% YoY), while the FY2025 annual figure was $2.0 billion, up 16.33% from the prior year.
- Cash & Equivalents came in at $1.9 billion for Q2 2026 at Iqvia Holdings, down from $1.9 billion in the prior quarter.
- In the past five years, Cash & Equivalents ranged from a high of $2.0 billion in Q2 2025 to a low of $1.2 billion in Q4 2022.
- Average Cash & Equivalents over 5 years is $1.6 billion, with a median of $1.5 billion recorded in 2023.
- Year-over-year, Cash & Equivalents sank 39.83% in 2022 and surged 31.97% in 2025.
- Over 5 years, Cash & Equivalents stood at $1.2 billion in 2022, then rose by 13.16% to $1.4 billion in 2023, then rose by 23.69% to $1.7 billion in 2024, then gained by 16.33% to $2.0 billion in 2025, then declined by 3.59% to $1.9 billion in 2026.
- Per Business Quant data, the three most recent Cash & Equivalents figures were $1.9 billion in Q2 2026, $1.9 billion in Q1 2026, and $2.0 billion in Q4 2025.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Equiv. (Qtr) |
|---|---|---|---|---|---|
| 1 | Iqvia Holdings | 44.72 Bn | 42.64 Bn | 1.44 Bn | 1.91 Bn |
| 2 | Medpace Holdings | 17.37 Bn | 16.87 Bn | 201.64 Mn | 502.69 Mn |
| 3 | Icon | 13.65 Bn | 12.72 Bn | 479.29 Mn | 928.39 Mn |
| 4 | Charles River Laboratories International | 13.13 Bn | 12.94 Bn | 452.07 Mn | 192.03 Mn |
| 5 | Fortrea Holdings | 1.89 Bn | 1.72 Bn | 139.20 Mn | 168.60 Mn |
| 6 | Evotec SE | 574.75 Mn | 148.87 Mn | - | 404.92 Mn |
| 7 | Ginkgo Bioworks Holdings | 439.63 Mn | 355.09 Mn | 18.44 Mn | 84.54 Mn |
| 8 | Champions Oncology | 69.43 Mn | 65.03 Mn | 7.70 Mn | 4.40 Mn |
| 9 | MindWalk Holdings | 51.76 Mn | 46.29 Mn | 1.61 Mn | 5.47 Mn |
| 10 | VivoSim Labs | 1.37 Mn | 1.37 Mn | - | 1.70 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.91 Bn |
| Mar 31, 2026 | 1.95 Bn |
| Dec 31, 2025 | 1.98 Bn |
| Sep 30, 2025 | 1.81 Bn |
| Jun 30, 2025 | 2.04 Bn |
| Mar 31, 2025 | 1.74 Bn |
| Dec 31, 2024 | 1.70 Bn |
| Sep 30, 2024 | 1.57 Bn |
| Jun 30, 2024 | 1.55 Bn |
| Mar 31, 2024 | 1.44 Bn |
| Dec 31, 2023 | 1.38 Bn |
| Sep 30, 2023 | 1.22 Bn |
| Jun 30, 2023 | 1.38 Bn |
| Mar 31, 2023 | 1.49 Bn |
| Dec 31, 2022 | 1.22 Bn |
| Sep 30, 2022 | 1.27 Bn |
| Jun 30, 2022 | 1.43 Bn |
| Mar 31, 2022 | 1.39 Bn |
| Dec 31, 2021 | 1.37 Bn |
| Sep 30, 2021 | 1.47 Bn |